The Schwab U.S. Dividend Equity ETF Is Near Its All-Time High: Is It Still a Good Buy?

Schwab U.S. Dividend Equity ETF (SCHD) has gained 22% year to date and yields 3.0%, materially above the S&P 500's 1.1% yield. Despite reaching an all-time high, the ETF's average P/E remains below 20 versus 23 for the S&P 500, supporting the view that it remains reasonably valued for income-oriented investors. SCHD has nonetheless lagged materially over five years, returning 36% versus nearly 80% for the S&P 500.

Analysis

This is not a company-specific catalyst and should not alter views on NFLX, NVDA, or GETY; their inclusion is promotional/metadata noise rather than an economic linkage. The relevant market signal is continued demand for quality-income exposure after a period in which mega-cap growth led returns. SCHD can attract incremental allocator flows if equity volatility rises or long-duration growth multiples de-rate, but its recent strength likely reflects factor rotation rather than a durable earnings reacceleration among its holdings.

The key sensitivity is rates, not the headline portfolio P/E. A renewed rise in real yields would pressure dividend-equity relative performance, particularly regulated utilities, REIT-adjacent exposures, and other bond proxies held across comparable funds; conversely, a 25-50 bp decline in the 10-year Treasury yield would likely broaden demand for SCHD and peers such as VYM and DGRO over the next one to three months. Financials are the important offset: a steepening curve can support bank earnings and partially cushion the ETF, while rapid Fed easing may reduce net-interest-income expectations.

Contrarianly, the apparent valuation discount should not be treated as automatic upside. Dividend screens systematically tilt toward slower organic growth and industries with elevated payout ratios, so the discount can persist absent a macro regime favoring cash yield. The more actionable structural question over six to eighteen months is whether dividend growth—not current yield—keeps pace with inflation and broad-market EPS; cuts or weak payout growth would remove the main reason for the factor premium. Falsification for a defensive-over-growth rotation is a sustained rise in the 10-year real yield alongside continued upward revisions for NVDA-led capex beneficiaries.

Key Decisions for Investors

• No directional trade in NFLX, NVDA, or GETY from this item; monitor only, as the article provides no incremental fundamental information for these names.
• For a tactical defensive allocation, consider a 1-3 month long SCHD / short SPY pair only if the 10-year Treasury yield declines materially and market breadth weakens; target modest factor capture rather than absolute-return beta. Exit if real yields rise or SCHD relative performance fails to improve after the next major inflation and payroll releases.
• Do not chase SCHD after a sharp inflow-driven move. Better entry is on a 3-5% pullback or after confirmation that constituent dividend-growth expectations remain intact; verify sector weights, top-ten concentration, and forward dividend revisions before sizing.
• Maintain NVDA as the cleaner opposite-side expression of a higher-real-yield, AI-capex-led regime rather than shorting SCHD outright. A SCHD/NVDA relative-value hedge is only appropriate if macro data begin to favor disinflation and growth-stock earnings revisions stop accelerating.